X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs FRESENIUS KABI ONCO. - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. FRESENIUS KABI ONCO. WOCKHARDT LTD./
FRESENIUS KABI ONCO.
 
P/E (TTM) x -11.0 22.1 - View Chart
P/BV x 2.2 3.1 70.1% View Chart
Dividend Yield % 1.5 0.0 -  

Financials

 WOCKHARDT LTD.   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
FRESENIUS KABI ONCO.
Mar-13
WOCKHARDT LTD./
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs1,129176 641.5%   
Low Rs62779 798.7%   
Sales per share (Unadj.) Rs363.137.7 963.6%  
Earnings per share (Unadj.) Rs-20.45.1 -401.5%  
Cash flow per share (Unadj.) Rs-7.06.7 -103.7%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs301.842.5 709.4%  
Shares outstanding (eoy) m110.55158.23 69.9%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.43.4 71.6%   
Avg P/E ratio x-42.925.0 -171.9%  
P/CF ratio (eoy) x-125.918.9 -665.1%  
Price / Book Value ratio x2.93.0 97.3%  
Dividend payout %-48.90-   
Avg Mkt Cap Rs m97,06320,135 482.1%   
No. of employees `0006.81.2 587.5%   
Total wages/salary Rs m9,665703 1,374.4%   
Avg. sales/employee Rs Th5,931.85,176.2 114.6%   
Avg. wages/employee Rs Th1,428.1610.4 233.9%   
Avg. net profit/employee Rs Th-334.0699.6 -47.7%   
INCOME DATA
Net Sales Rs m40,1465,963 673.3%  
Other income Rs m1,14318 6,347.2%   
Total revenues Rs m41,2895,981 690.3%   
Gross profit Rs m1281,430 9.0%  
Depreciation Rs m1,489258 577.5%   
Interest Rs m2,253-26 -8,664.2%   
Profit before tax Rs m-2,4721,216 -203.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m-211342 -61.7%   
Profit after tax Rs m-2,260806 -280.5%  
Gross profit margin %0.324.0 1.3%  
Effective tax rate %8.528.1 30.4%   
Net profit margin %-5.613.5 -41.7%  
BALANCE SHEET DATA
Current assets Rs m46,1605,102 904.8%   
Current liabilities Rs m19,2582,385 807.3%   
Net working cap to sales %67.045.6 147.1%  
Current ratio x2.42.1 112.1%  
Inventory Days Days101150 67.1%  
Debtors Days Days94113 83.0%  
Net fixed assets Rs m40,1655,148 780.2%   
Share capital Rs m553158 349.4%   
"Free" reserves Rs m32,8146,556 500.6%   
Net worth Rs m33,3676,732 495.7%   
Long term debt Rs m31,903952 3,350.4%   
Total assets Rs m89,68710,388 863.4%  
Interest coverage x-0.1-45.8 0.2%   
Debt to equity ratio x1.00.1 675.9%  
Sales to assets ratio x0.40.6 78.0%   
Return on assets %07.5 -0.1%  
Return on equity %-6.812.0 -56.6%  
Return on capital %-0.314.6 -2.3%  
Exports to sales %074.5 0.0%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m9,1215,298 172.2%   
Fx outflow Rs m2,1331,772 120.4%   
Net fx Rs m6,9883,525 198.2%   
CASH FLOW
From Operations Rs m-2,6951,274 -211.5%  
From Investments Rs m-6,863-1,204 569.9%  
From Financial Activity Rs m12,545-196 -6,397.2%  
Net Cashflow Rs m3,010-126 -2,383.5%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 2.3 0.3 766.7%  
FIIs % 7.7 9.6 80.2%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 9.1 169.2%  
Shareholders   67,757 42,599 159.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON LTD  CIPLA  ABBOTT INDIA  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jun 25, 2018 03:35 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS